Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 23, 2006 - Issue 6
Submit an article Journal homepage
49
Views
5
CrossRef citations to date
0
Altmetric
Article

INCREASED EXPRESSION OF MULTIDRUG RESISTANCE GENE (MDR1) AT RELAPSE IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Maria Kourti Second Department of Pediatrics, Division of Pediatric Hematology and Oncology, Aristotle University of Thessaloniki, Thessaloniki, Greece
, MD, MSc,
Norma Vavatsi Professor of Clinical Biochemistry, Department of Biochemistry, Medical School, Aristotle University of Thessaloniki, Greece
, MD, PhD,
Nikolaos Gombakis Associate Professor of Pediatrics, First Department of Pediatrics, Aristotle University of Thessaloniki, Greece
, MD, PhD,
George Tzimagiorgis Lecturer of Biochemistry, Department of Biochemistry, Medical School, Aristotle University of Thessaloniki, Greece
, PhD,
Vasiliki Sidi Consultant in Pediatric Hematology and Oncology, Pediatric Hematology and Oncology Clinic, Hippokration Hospital of Thessaloniki,
, MD, PhD,
Dimitrios Koliouskas Director of Pediatric Hematology and Oncology Clinic, Hippokration Hospital of Thessaloniki,
, MD, PhD &
Fani Athanassiadou Professor of Pediatrics, Second Department of Pediatrics, Division of Pediatric Hematology and Oncology, Aristotle University of Thessaloniki, Thessaloniki, Greece
, MD, PhD show all
Pages 489-494 | Received 11 Jan 2006, Accepted 27 Mar 2006, Published online: 09 Jul 2009

REFERENCES

  • Den Boer M L, Harms D O, Pieters R, et al. Patient stratification based on prednisolone–vincristine–asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol. 2003; 21: 3262–3268, [INFOTRIEVE], [CSA]
  • Lawson S E, Harrison G, Richards S, et al. The UK experience in treating relapsed childhood acute lymphoblastic leukemia: a report on the medical research council UKALLR1 study. Br J Haematol. 2000; 108: 531–543, [INFOTRIEVE], [CSA], [CROSSREF]
  • Safa A R. Multidrug resistance. Principles of Antineoplastic Drug Development and Pharmacology, R Schilsky, M J Ratain, G Milano. Dekker, New York 1996; 457–486
  • Gottesmann M M, Fojo T, Bates S E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48–58, [CSA], [CROSSREF]
  • Sonneveld P. Multidrug resistance in haematological malignancies. J Intern Med. 2000; 247: 521–534, [INFOTRIEVE], [CSA]
  • Kotewitz M L, D'Alessio J M, Driftmier K M, et al. Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli. Gene. 1985; 35: 249–258, [CSA], [CROSSREF]
  • Kakihara T, Tanaka A, Watanabe A, et al. Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukaemia. Pediatr Int 1999; 41: 641–647, [INFOTRIEVE], [CSA]
  • Pui C. H., Schrappe M, Ribeiro R C, et al. Childhood and adolescent lymphoid and myeloid leukemia. 2004; 118–124, Hematology
  • Winick N J, Carroll W L, Hunger S P. Childhood leukemia—new advances and challenges. N Engl J Med. 2004; 351: 601–603, [INFOTRIEVE], [CSA], [CROSSREF]
  • Schrappe M. Evolution of BFM trials. 2004; 118–145, Hematology
  • van d en, Heuvel-Eibrink M M, Sonnenveld P, Pieters R. The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukaemia. Int J Clin Pharmacol Ther. 2000; 38: 94–110, [CSA]
  • Tafuri A, Sommaggio A, Burba L, et al. Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia. Leuk Res. 1955; 19: 927, [CSA], [CROSSREF]
  • Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V. Expression of MDR1, MRP, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Haematol. 1995; 89: 356, [INFOTRIEVE], [CSA]
  • Beck J, Handgretinger R, Klingebiel T, et al. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia. 1996; 10: 426, [INFOTRIEVE], [CSA]
  • Ivy S P, Olshefski R S, Taylor B J, Patel K M, Reaman G H. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a Children's Cancer Group study. Blood. 1996; 88: 309, [INFOTRIEVE], [CSA]
  • Goasguen J E, Dossot J M, Fardel O, et al. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood. 1993; 81: 2394, [INFOTRIEVE], [CSA]
  • Sievers E L, Smith F O, Woods W G, et al. Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group. Leukemia. 1995; 9: 2042, [INFOTRIEVE], [CSA]
  • den Boer M L, Pieters R, Kazemier K M. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood 1998; 91: 2092–2098, [INFOTRIEVE], [CSA]
  • Wuchter C, Leonid K, Ruppert V, et al. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica. 2000; 85: 711–721, [INFOTRIEVE], [CSA]
  • Yague E, Armesilla A L, Harrison G, et al. P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem. 2003; 278: 10344–10352, [INFOTRIEVE], [CSA], [CROSSREF]
  • Szczepanski T, Orfao A, van der Velden V H, et al. Minimal residual disease in leukaemia patients. Lancet Oncol. 2001; 2: 409–417, [INFOTRIEVE], [CSA], [CROSSREF]
  • Yeoh E J, Ross M E, Shurtleff S A, et al. Classification, subtype discovery,and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1: 133–143, [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.